Scientis

🚨 Exciting Research Update! 🚨 We are thrilled to share the findings from our recent studies that further demonstrate the effectiveness of Cyspera® with cysteamine in managing various pigmentation disorders, including melasma-prone skin, post-inflammatory hyperpigmentation (PIH), and solar lentigines. 🌟 Highlights: Melasma: Cysteamine cream proved as effective as hydroquinone, offering comparable results with fewer side effects, making it a safer option for long-term use. PIH: Cysteamine significantly reduced pigmentation, delivering results on par with hydroquinone 4%/ascorbic acid 3% while improving patient quality of life. Solar Lentigines: After 12 weeks, stabilized cysteamine reduced pigmentation by 40%, far outperforming the control group. These results showcase the power of Cyspera® as a trusted solution for managing pigmentation disorders while maintaining safety and high patient satisfaction. 🌟✨ Let’s continue the journey to radiant, healthy skin! 💫 #Dermatology #PigmentationTreatment #Cyspera #Cysteamine #Skincare #Melasma #PIH #Lentigines #SkinHealth #Innovation #ClinicalResearch

🚀 For those who don't know us yet: We're Scientis , the leading authority in pigmentation science and the innovative force behind Cyspera®, a game-changing solution for hyperpigmentation. Our journey began with the visionary leadership of Dr. Behrooz Kasraee, a pioneer in dermatological research . Dr. Kasraee founded Scientis with a mission to tackle complex skin conditions, particularly hyperpigmentation, by leveraging cutting-edge science. Cyspera® is a testament to that mission—an advanced, non-hydroquinone pigment corrector designed to safely and effectively address hyperpigmentation. It's a product born from years of research, a deep understanding of skin biology, and a commitment to empowering people to feel confident in their skin. At Scientis , we are proud to be recognized as the experts in pigmentation. We push the boundaries of science to deliver transformative results in the fight against hyperpigmentation. We're excited to continue this journey and bring innovative solutions to dermatology professionals and individuals worldwide. Thank you for being part of our story. Together, we can make a difference in the world of hyperpigmentation. 🌟   #Scientis #Cyspera #Hyperpigmentation #Dermatology #PigmentationAuthority 

We're #hiring a new Supply Chain Director in Geneva, Geneva. Apply today or share this post with your network.

🌟 July is Melasma Awareness Month! 🌟 Melasma, often called the "mask of pregnancy," is a common skin condition that causes brown patches, typically on the face. It's more prevalent in women and can affect self-esteem and confidence. Let's raise awareness about Melasma, its causes, and treatment options. Early detection and proper skincare can make a significant difference. Share your stories, support each other, and spread the word! 🗣️💬 #MelasmaAwareness #SkinHealth #SupportAndEducate #Dermatology #SelfCare #SkincareCommunity

🌟We're Honored! Cyspera Boost™ has been awarded Best Luxury Anti – Ageing Serum. Experience the award-winning formula for yourself. 🌟 #AwardWinning #CysperaBoost #HyperpigmentationFree #SummerGlow #SkinHealth

Cyspera Intensive™ has won 2024 NewBeauty Award “Best Cysteamine Treatment”. 🏆 ✨ Learn more: https://lnkd.in/eafDxQna

Cyspera is going to be at #AMWC in Monaco! 🇲🇨 Looking forward to connecting with professionals from all over the world and learning more about the latest trends in aesthetics. See you there!

🌟 Did you know the power of Cysteamine Isobionic-Amide Complex™ in improving the appearance of post-inflammatory hyperpigmentation (PIH), specifically postlaser and postacne hyperpigmentation? 💡Check out the recent study published in Dermatologica Sinica, a reputed research journal: "Efficacy and safety of cysteamine‑isobionicamide complex in postinflammatory hyperpigmentation: A 16‑week, randomized, double‑blinded, vehicle‑controlled trial”. It demonstrated the clinical effectiveness and safety of the Cysteamine Isobionic-Amide Complex™ through comprehensive dermatological assessments, imaging techniques, and patient‑reported outcomes. 📖 Read it here: https://lnkd.in/e3ehSEaQ

📚 Scientis is proud to share with you the new scientific article, published in the renowned Journal of Drugs in Dermatology in February 2024: Cysteamine Isobionic-Amide Complex™ Versus Kligman’s Formula for the Treatment of Melasma: Equal Efficacy and Rapid Onset of Action. Read it here: https://lnkd.in/ebpEwwt3

Dr. Behrooz KASRAEE - our Chief Scientific Officer - will be speaking at the IMCAS World Congress 2024 about "Isobionic-Amide as a new depigmenting and anti-inflammatory molecule and its combination with other depigmenting agents". See you there! 🇫🇷